CDH2 and hepatocellular carcinoma: Our research illustrates that RIPK4 can reduce the expression of N-cadherin, Zeb-1, and vimentin in HCC, and our research also found that RIPK4 can regulate HCC EMT and reduce the invasion and metastasis of HCC cells.